Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints

Thumbnail Image
Keane_et_al_2022.pdf(1.65 MB)
Accepted version
41416_2022_2062_MOESM1_ESM.pdf(424.32 KB)
Additional file 1
41416_2022_2062_MOESM2_ESM.pdf(110.91 KB)
Additional file 2
41416_2022_2062_MOESM3_ESM.pdf(112.73 KB)
Additional file 3
41416_2022_2062_MOESM4_ESM.pdf(1.91 MB)
Additional file 4
Keane, Jonathan M.
Walsh, Calum J.
Cronin, P.
Baker, Kevin J.
Melgar, Silvia
Cotter, Paul D.
Joyce, Susan A.
Gahan, Cormac G. M.
Houston, Aileen M.
Hyland, Niall P.
Journal Title
Journal ISSN
Volume Title
Springer Nature
Research Projects
Organizational Units
Journal Issue
Background: Distinct sets of microbes contribute to colorectal cancer (CRC) initiation and progression. Some occur due to the evolving intestinal environment but may not contribute to disease. In contrast, others may play an important role at particular times during the tumorigenic process. Here, we describe changes in the microbiota and host over the course of azoxymethane (AOM)-induced tumorigenesis. Methods: Mice were administered AOM or PBS and were euthanised 8, 12, 24 and 48 weeks later. Samples were analysed using 16S rRNA gene sequencing, UPLC-MS and qRT-PCR. Results: The microbiota and bile acid profile showed distinct changes at each timepoint. The inflammatory response became apparent at weeks 12 and 24. Moreover, significant correlations between individual taxa, cytokines and bile acids were detected. One co-abundance group (CAG) differed significantly between PBS- and AOM-treated mice at week 24. Correlation analysis also revealed significant associations between CAGs, bile acids and the bile acid transporter, ASBT. Aberrant crypt foci and adenomas were first detectable at weeks 24 and 48, respectively. Conclusion: The observed changes precede host hyperplastic transformation and may represent early therapeutic targets for the prevention or management of CRC at specific timepoints in the tumorigenic process.
Colon cancer , Microbiome , Colorectal cancer (CRC) , Microbiota , Tumorigenesis
Keane, J.M., Walsh, C.J., Cronin, P., Baker, K., Melgar, S., Cotter, P.D., Joyce, S.A., Gahan, C.G.M., Houston, A., and Hyland, N.P. (2022) ‘Investigation of the gut microbiome, bile acid composition and host immunoinflammatory response in a model of azoxymethane-induced colon cancer at discrete timepoints’, British Journal of Cancer,
Link to publisher’s version
© The Author(s),This version of the article has been accepted for publication, after peer review and is subject to Springer Nature’s AM terms of use, but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: